It’s About Time
A rare convergence of breakthroughs in biotechnology and computational biology is creating one of the most compelling investment opportunities of our generation. Longevity Angels gives accredited investors curated, early-stage access to the companies leading this transformation
About the Network
The Longevity Angels are a group of investors supporting early-stage biotechnology companies developing therapies that target the underlying biology of aging.
We bring together founders in gerontology and rejuvenation medicine with individual investors who share a long-term interest in advancing human healthspan and lifespan.
Our approach emphasizes thoughtful deal selection and reasonable minimum investment sizes, enabling accredited investors of all levels to participate.
Investment Process
-
The Longevity Angels team carefully curates deals, ensuring they provide access to companies with revolutionary technology and promising exit opportunities. Each portfolio company undergoes a thorough evaluation process before being presented to investors, allowing only a select few to receive funding. This selectivity is intentional. Longevity Angels’ portfolio companies are revolutionizing the ways we age, in real time.
-
Longevity Angels structures each deal through a Special Purpose Vehicle (SPV); No blind-pool funds, full transparency. Our deal-by-deal structure gives investors full discretion over the companies they back and the amount they invest. Investors have direct access to executives at Longevity Angels’ portfolio companies. Additionally, the terms of each deal are carefully negotiated to ensure clients receive the highest potential return on investment.
-
We believe trust is built through transparency. Longevity Angels provides full access to all available diligence materials for each offering. Investors are invited to meet with executives and ask any questions they may have. The investment experience is far greater than writing a check, your confidence in the company is our priority.
-
Each Longevity Angels offering is structured through Sydecar, a purpose-built venture investing platform. Each step of the investment process from subscription documents to wiring instructions is handled on Sydecar. Investors can view committed capital, investment documents, and compliance filings across all Longevity Angels deals through one intuitive dashboard.
-
Longevity Angels manages all annual reporting on behalf of each SPV, including K-1s, year-end statements, and any required regulatory filings. Tax documents are sent through Sydecar and our team is available to field any questions regarding tax and compliance.
-
An investment with Longevity Angels is far more than a transaction. Once you’ve invested, you join a community of passionate investors with strong belief in the future of longevity. There’s no obligation to invest in every offering, but you’ll always have a seat at the table.